XML 69 R55.htm IDEA: XBRL DOCUMENT v3.3.1.900
Notes Payable (Details)
12 Months Ended
Jan. 11, 2016
USD ($)
Dec. 05, 2013
USD ($)
Dec. 31, 2015
USD ($)
Installment
Dec. 31, 2014
USD ($)
Clinic
Installment
Dec. 31, 2013
USD ($)
Installment
Debt Instrument [Line Items]          
Number of annual installments | Installment     2    
Aggregate principal payment due in 2016     $ 775,000    
Aggregate principal payment due in 2017     559,000    
Aggregate principal payment due in 2018     45,930,000    
Aggregate principal payment due in 2019     1,846,000    
Number of clinic-practice acquisition | Clinic       13  
Notes Payable, Other Payables [Member]          
Debt Instrument [Line Items]          
Aggregate amount of notes payable       $ 500,000 $ 1.3
Aggregate principal installments       $ 233,000 $ 650,000
Average effective interest rate       3.25% 3.25%
Number of annual installments | Installment       2 2
Notes Payable [Member]          
Debt Instrument [Line Items]          
Aggregate amount of notes payable     4,900,000    
Aggregate principal payment due in 2016     575,000    
Aggregate principal payment due in 2017     525,000    
Aggregate principal payment due in 2018     1,900,000    
Aggregate principal payment due in 2019     $ 1,900,000    
Minimum [Member]          
Debt Instrument [Line Items]          
Spread on Libor variable rate     1.50%    
Spread on base variable rate     0.10%    
Percentage of unused commitment fee     0.10%    
Minimum [Member] | Notes Payable [Member]          
Debt Instrument [Line Items]          
Average effective interest rate     3.25%    
Maximum [Member]          
Debt Instrument [Line Items]          
Spread on Libor variable rate     2.50%    
Spread on base variable rate     1.00%    
Percentage of unused commitment fee     0.25%    
Maximum [Member] | Notes Payable [Member]          
Debt Instrument [Line Items]          
Average effective interest rate     3.50%    
Credit Agreement [Member]          
Debt Instrument [Line Items]          
Cash and noncash consideration with respect to acquisition $ 25,000,000        
Cash and noncash consideration with respect to acquisition after amendment 50,000,000        
Cash dividends 7,500,000        
Cash dividends after amendment $ 10,000,000        
Credit Facility [Member]          
Debt Instrument [Line Items]          
Revolving credit facility commitment   $ 125,000,000      
Revolving credit facility maturity date   Nov. 30, 2018      
Remaining revolving credit outstanding     $ 81,000,000    
Average effective interest rate     2.50%